RNK-08954

N/A

Report date: 2026/03/24 20:00:35
NME

Base Information

Drug NameRNK-08954
Drug Alias NameRNK08954RNK-08954
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKRAS G12D inhibitors
TargetsKRAS G12D
Therapy Area/IndicationsSolid tumoursPancreatic NeoplasmsCarcinoma, Pancreatic Ductal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursPancreatic NeoplasmsCarcinoma, Pancreatic Ductal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A